Αποτελέσματα αναζήτησης - David Burden
- Εμφανίζονται 1 - 20 Αποτελέσματα από 60
- Μετάβαση στην Επόμενη Σελίδα
-
1
-
2
Digital Immortality and Virtual Humans από Maggi Savin‐Baden, David Burden
Έκδοση 2018Artigo -
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
A synonymous SNP of the corneodesmosin gene leads to increased mRNA stability and demonstrates association with psoriasis across diverse ethnic groups από Francesca Capon, Michael H. Allen, Mahreen Ameen, A. David Burden, David M. Tillman, Juliet N. Barker, Richard C. Trembath
Έκδοση 2004Artigo -
11
-
12
Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Stu... από A. David Burden, Robert Bissonnette, Alexander A. Navarini, Masamoto Murakami, Akimichi Morita, Thomas Haeufel, Binqi Ye, Frank Baehner, Tadashi Terui
Έκδοση 2023Artigo -
13
-
14
Psychometric validation of the generalized pustular psoriasis physician global assessment (<scp>GPPGA</scp>) and generalized pustular psoriasis area and severity index (<scp>GPPASI... από A. David Burden, Robert Bissonnette, Mark Lebwohl, Tristan Gloede, Milena Anatchkova, Ismail Budhiarso, Na Hu, Christian Thoma, Anne Skalicky, H. Bachelez
Έκδοση 2023Artigo -
15
Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind, Randomized, Placebo-Controlled Pi... από Ulrich Mrowietz, A. David Burden, Andreas Pinter, Kristian Reich, Knut Schäkel, Patrick Baum, Yakov Datsenko, Hongjie Deng, Steven J. Padula, Christian Thoma, Robert Bissonnette
Έκδοση 2021Artigo -
16
Efficacy of spesolimab for the treatment of generalized pustular psoriasis flares across pre‐specified patient subgroups in the Effisayil 1 study από A. David Burden, Yukari Okubo, Min Zheng, Diamant Thaçi, P.C.M. van de Kerkhof, Na Hu, Manuel Quaresma, Christian Thoma, Siew Eng Choon
Έκδοση 2023Artigo -
17
Risk of major cardiovascular events in patients with psoriasis receiving biologic therapies: a prospective cohort study από Watcharee Rungapiromnan, K.J. Mason, Mark Lunt, Kathleen McElhone, A. David Burden, Martin K. Rutter, Richard B. Warren, C.E.M. Griffiths, Darren M. Ashcroft
Έκδοση 2019Artigo -
18
Circulating tumour necrosis factor is highly correlated with brainstem serotonin transporter availability in humans από Rajeev Krishnadas, Alice Nicol, Jen Sassarini, Navesh Puri, A. David Burden, Joyce Leman, Emilie Combet, Sally L. Pimlott, Donald M. Hadley, Iain B. McInnes, Jonathan Cavanagh
Έκδοση 2015Artigo -
19
The Major Psoriasis Susceptibility Locus PSORS1 Is not a Risk Factor for Late-Onset Psoriasis από Michael H. Allen, Hahreen Ameen, Colin Veal, Julie Evans, V.S. Ramrakha‐Jones, Alexander Marsland, A. David Burden, C.E.M. Griffiths, Richard C. Trembath, Juliet N. Barker
Έκδοση 2005Artigo -
20
Family-Based Analysis Using a Dense Single-Nucleotide Polymorphism–Based Map Defines Genetic Variation at PSORS1, the Major Psoriasis-Susceptibility Locus από Colin Veal, Francesca Capon, Michael H. Allen, Emma Heath, Julie Evans, A. Rocyn Jones, Shanta Patel, David Burden, David M. Tillman, Juliet N. Barker, Richard C. Trembath
Έκδοση 2002Artigo
Εργαλεία αναζήτησης:
Σχετικά θέματα
Medicine
Psoriasis
Dermatology
Biology
Internal medicine
Genetics
Gene
Immunology
Pathology
Disease
Genotype
Single-nucleotide polymorphism
Generalized pustular psoriasis
Genome-wide association study
Adalimumab
Allele
Locus (genetics)
Pustular psoriasis
Ustekinumab
Genetic association
Phenotype
Psoriatic arthritis
Adverse effect
Alternative medicine
Clinical endpoint
Clinical trial
Cohort
Etanercept
Placebo
Psoriasis Area and Severity Index